Literature DB >> 17919625

The endothelin axis and gelatinase activity in alveolar macrophages after brain-stem death injury: a pilot study.

Allison J Sutherland1, Robert S Ware, Clay Winterford, John F Fraser.   

Abstract

BACKGROUND: Endothelin-1 (ET-1) is a potent vasoconstricting mitogen that has been implicated in the development of primary graft dysfunction. Increased activity of matrix metalloproteinases (MMPs), specifically MMP-2 and -9, has been associated with tissue damage in acute lung injury and after lung transplantation. Using a validated model of brain-stem death (BSD), we aimed to determine whether alveolar macrophage up-regulation in the pulmonary system is an early feature of BSD injury and if expression levels of ET-1, endothelin A receptors (ET(A)R) and endothelin B receptors (ET(B)R), as well as MMP-2 and -9, are increased in comparison to sham controls.
METHODS: Six control and 8 experimental Wistar-Kyoto rats had a balloon catheter inserted into their subdural space. In the experimental group the balloon was inflated for 4 hours. Lung specimens were immunohistochemically labeled with CD68, ET-1, ET(A)R, ET(B)R, MMP-2 and MMP-9, and 10 fields per slide were assessed.
RESULTS: The ratio of alveolar macrophages to polymorphonuclear neutrophils was significantly greater in the BSD group than in controls (9 +/- 4.1 vs 3 +/- 0.5, p = 0.004) and adventitial macrophages increased in BSD lung parenchyma (p < 0.0001). ET-1, ET(A)R and ET(B)R levels were elevated in the experimental group (27.6 +/- 5.7 vs 7 +/- 2.3, 36.1 +/- 4.6 vs 17.7 +/- 2.6 and 60 +/- 7.1 vs 19.8 +/- 3.7, p < 0.0001 inclusive). BSD expression of MMP-2 and MMP-9 was double that of controls (14.9 +/- 3.4 vs 30.7 +/- 3.4 and 14.2 +/- 2.2 vs 37 +/- 3.6, respectively, p < 0.0001 inclusive).
CONCLUSIONS: Alveolar macrophages are rapidly recruited after BSD and may affect peri-operative lung function via increased expression of ET-1, ET(A)R, ET(B)R, MMP-2 and MMP-9.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17919625     DOI: 10.1016/j.healun.2007.07.013

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  7 in total

Review 1.  Special issues in the management and selection of the donor for lung transplantation.

Authors:  Priyumvada M Naik; Luis F Angel
Journal:  Semin Immunopathol       Date:  2011-04-15       Impact factor: 9.623

2.  A sphingosine 1-phosphate 1 receptor agonist modulates brain death-induced neurogenic pulmonary injury.

Authors:  Saad Sammani; Ki-Sung Park; Syed R Zaidi; Biji Mathew; Ting Wang; Yong Huang; Tong Zhou; Yves A Lussier; Aliya N Husain; Liliana Moreno-Vinasco; Wickii T Vigneswaran; Joe G N Garcia
Journal:  Am J Respir Cell Mol Biol       Date:  2011-05-26       Impact factor: 6.914

3.  Juguloarterial endothelin-1 gradients after severe traumatic brain injury.

Authors:  Doris A Chatfield; Darshan H Brahmbhatt; Tilly Sharp; Iain E Perkes; Joanne G Outrim; David K Menon
Journal:  Neurocrit Care       Date:  2011-02       Impact factor: 3.210

4.  Selection of reference genes for normalisation of real-time RT-PCR in brain-stem death injury in Ovis aries.

Authors:  Margaret Passmore; Maria Nataatmadja; John F Fraser
Journal:  BMC Mol Biol       Date:  2009-07-23       Impact factor: 2.946

5.  Inflammatory signalling associated with brain dead organ donation: from brain injury to brain stem death and posttransplant ischaemia reperfusion injury.

Authors:  Ryan P Watts; Ogilvie Thom; John F Fraser
Journal:  J Transplant       Date:  2013-04-15

6.  Novel 24-h ovine model of brain death to study the profile of the endothelin axis during cardiopulmonary injury.

Authors:  Ryan P Watts; Izabela Bilska; Sara Diab; Kimble R Dunster; Andrew C Bulmer; Adrian G Barnett; John F Fraser
Journal:  Intensive Care Med Exp       Date:  2015-11-24

7.  Endothelin receptor antagonist improves donor lung function in an ex vivo perfusion system.

Authors:  K Walweel; K Skeggs; A C Boon; L E See Hoe; M Bouquet; N G Obonyo; S E Pedersen; S D Diab; M R Passmore; K Hyslop; E S Wood; J Reid; S M Colombo; N J Bartnikowski; M A Wells; D Black; L P Pimenta; A K Stevenson; K Bisht; L Marshall; D A Prabhu; L James; D G Platts; P S Macdonald; D C McGiffin; J Y Suen; J F Fraser
Journal:  J Biomed Sci       Date:  2020-10-02       Impact factor: 8.410

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.